Kymera Therapeutics Inc (KYMR)
32.11
-0.05
(-0.16%)
USD |
NASDAQ |
May 31, 16:00
32.10
-0.02
(-0.05%)
After-Hours: 20:00
Kymera Therapeutics Revenue (TTM): 79.41M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 79.41M |
December 31, 2023 | 78.59M |
September 30, 2023 | 46.85M |
June 30, 2023 | 51.67M |
March 31, 2023 | 46.67M |
December 31, 2022 | 46.83M |
September 30, 2022 | 45.96M |
June 30, 2022 | 56.75M |
Date | Value |
---|---|
March 31, 2022 | 63.75M |
December 31, 2021 | 72.83M |
September 30, 2021 | 70.34M |
June 30, 2021 | 64.54M |
March 31, 2021 | 49.31M |
December 31, 2020 | 34.03M |
September 30, 2020 | 23.08M |
June 30, 2020 | 9.499M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
9.499M
Minimum
Jun 2020
79.41M
Maximum
Mar 2024
52.51M
Average
50.49M
Median